EA1131
A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Breast Cancer following Neoadjuvant Chemotherapy
Trial overview
| Disease | Breast cancer treatment and diagnosis |
| Topic | EA1131 |
| Description | Primary Objective To compare the IDFS in TNBC patients with residual basal-like disease after neoadjuvant chemotherapy who are randomized to postpreoperative platinum-based chemotherapy with those who are randomized to capecitabine |
| Physicians | Dr. Mohammad JahanzebMD, FACP, FASCO Medical Oncologist Works at 2 centers.Dr. Edgardo SantosMD Medical Oncologist Aventura (Medical oncology) |
| Location | Warning: count(): Parameter must be an array or an object that implements Countable in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 299 Warning: Invalid argument supplied for foreach() in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 301 |